FindTrial
Sign In

Study on the mechanism of UCP in the treatment of glaucoma

Long-term efficacy, safety and influencing factors of high intensity focused ultrasound cycloplasty: A Multicenter Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500103354
Enrollment
Unknown
Registered
2025-05-28
Start date
2021-11-01
Completion date
Unknown
Last updated
2025-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma

Interventions

Patients receiving UCP treatment:None

Sponsors

Chongqing Aier Ophthalmology Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: All patients who have been treated with UCP for 6 months or more in the 6 Aier Eye Hospitals in this study. The case information is complete, and they can undergo follow-up examinations and sign the informed consent form.

Exclusion criteria

Exclusion criteria: a) Refusal of informed consent. b) Patients who cannot be followed up due to force majeure.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;visual acuity (best corrected visual acuity);drug usage;—

Secondary

MeasureTime frame
anterior chamber depth;complications situation;—

Countries

China

Contacts

Public ContactHe Xiangge

Chongqing Aier Eye Hospital

hexiangge2011@126.com+86 136 0832 0507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026